Immunotherapy for the treatment and prevention of inflammatory bowel disease
AssigneeThe UAB Research Foundation
InventorsCharles O. Elson, Wayne Duck, Qing Zhao, Katie Alexander
Life of this patent
Estimating the term…
Abstract
Provided herein are methods and compositions for treating and preventing inflammatory bowel disease.
Claims31
A method for treating or preventing inflammatory bowel disease comprising administering to a subject having inflammatory bowel disease or at risk of developing inflammatory bowel disease
- a) an effective amount of a polypeptide comprising one or more flagellin T-cell receptor (TCR) epitopes;
- and
- b) an effective amount of an agent that reduces flagellin antigen-specific memory T cells and/or increases regulatory T cells in the subject.
A method for delaying or reducing the intensity of a relapse or flare of an inflammatory bowel disease in a subject comprising administering to a subject
- a) an effective amount of a polypeptide comprising one or more flagellin T-cell receptor (TCR) epitopes;
- and
- b) an effective amount of an agent that increases regulatory T cells in the subject.
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
(canceled)
A polypeptide comprising an amino acid sequence having at least 80% identity to SEQ ID NO:
- 4 or SEQ ID NO:
- 5, wherein the polypeptide is not a full-length flagellin polypeptide sequence.
Dependencies are inferred from the claim text.